Methodology The ranking of Asia’s richest families was compiled as of Jan. 31, 2025. It excludes first-generation wealth such ...
In the Indian stock market, FIIs are booking profits, domestic investors are treading carefully, and valuations are stretched ...
Currrax Pharmaceuticals over-performed its 2024 revenue goal and has exceeded 50% year-over-year revenue growth for its ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says ...
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Oric Pharmaceuticals (ORIC – Research Report), Inmune Bio (INMB – Research Report) and Vertex ...